Vasodilation by urapidil in the treatment of chronic congestive heart failure in addition to angiotensinconverting enzyme inhibitors is not beneficial: Results of a placebo-controlled, double-blind study
Axel Dorszewski, Ekbert Gohmann, Barbara Dorszewski, Gerald S. Werner, Heinrich Kreuzer, Hans R. FigullaVolume:
3
Year:
1997
Language:
english
DOI:
10.1016/s1071-9164(97)90040-3
File:
PDF, 525 KB
english, 1997